Company Team
Peptide Chemistry & Virology
Dr. Wuyuan Lu
- Over 30 years of research experience in antimicrobial peptides, peptide chemistry and biochemistry, virology
- Currently professor at Maryland University, Greenebaum Cancer Center
- Ph.D. in Biochemistry from Purdue University; Postdoc research in the Scripps Institute and the University of Chicago.
Peptide Med-Chem, Delivery and CMC
Dr. Ved Srivastava
- CTO at Perpetual Medicines and Ex-VP of Chemistry at Atkis Oncology. Previously, VP of Peptide Chemistry at Intarcia Therapeutics, Head of Peptide Chemistry at GSK; and peptide scientist at Amylin (AZ)
- Ex-President of the American Peptide Society (2019-2021)
- Over 25 years of experience in drug discovery and development in metabolic diseases, CNS, and inflammation
- Significantly participated in the development Symlin™, Byetta™, and Bydeureo™, first- in-class medicines for diabetes
MD Simulation & Machine Learning
Dr. Yu-Shan Lin
- Expert in molecular dynamics simulation and machine learning for rapid structure prediction of cyclic peptides on a large scale
- Associate Professor in the Department of Chemistry at Tufts University with over 14 years of research experience
- Professor Lin’s lab focuses on understanding and designing structures and properties of peptides, in particular cyclic and other restrained peptides
- Ph.D. in Chemistry from UW– Madison in 2009 and postdoc from Stanford as a Bio-X postdoctoral fellow
Peptide Chemistry and GPCR Drug Discovery
Dr. John Mayer
- Over 30 years of experience in natural peptide synthesis and GPCR drug discovery with focus on endocrine/diabetes therapeutics
- Advanced six molecules into clinical trials
- Currently, research Scientist in the Molecular, Cellular, and Developmental Biology Department at the University of Colorado, Boulder
- Ex-head of peptide discovery groups of Amgen & Lilly Research Labs. Principal Scientist at Novo Nordisk
Structural Biology
Dr. Zongchao Jia
- Expert in structural biology with over 25 years of experience in protein structure-function studies, kinases and phosphatases, calcium-binding proteins, and proteins from human pathogens
- Professor of Biochemistry, Queen’s University
- Ph.D. from University of Saskatchewan, post-doctoral training at the University of Oxford
PepLib aims to promote the development and accessibility of innovative peptide drugs, benefiting global patients and human health while keeping costs low.
Copyright©2023 Zonsen PepLib Biotech Inc. This website supports IPV6
Business License